Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
New drug compounds show promise in treating acute myeloid leukemia

New drug compounds show promise in treating acute myeloid leukemia

New approach identifies epigenetic changes in leukemia cells for patients undergoing ibrutinib treatment

New approach identifies epigenetic changes in leukemia cells for patients undergoing ibrutinib treatment

Targeting Sirt-1 enzyme shows promise in controlling graft-vs-host disease

Targeting Sirt-1 enzyme shows promise in controlling graft-vs-host disease

Study: Prolonged presence of precursor cells in thymus may give rise to leukemia

Study: Prolonged presence of precursor cells in thymus may give rise to leukemia

Novel therapeutic approach for treatment of leukemia

Novel therapeutic approach for treatment of leukemia

Study: Long-term spaceflights could adversely affect astronauts' immune systems

Study: Long-term spaceflights could adversely affect astronauts' immune systems

New study extends our knowledge of the link between miRNAs and cancer

New study extends our knowledge of the link between miRNAs and cancer

Behavioral experiments confirm that additional neurons improve brain function

Behavioral experiments confirm that additional neurons improve brain function

Beckman Coulter launches new ClearLLab 10C System for clinical flow cytometry lab

Beckman Coulter launches new ClearLLab 10C System for clinical flow cytometry lab

Researchers discover mechanism which drives leukemia cell growth

Researchers discover mechanism which drives leukemia cell growth

Researchers identify multiple new subtypes of most common childhood cancer

Researchers identify multiple new subtypes of most common childhood cancer

Cancer patients are four times more likely to commit suicide

Cancer patients are four times more likely to commit suicide

To get mental health help for a child, desperate parents relinquish custody

To get mental health help for a child, desperate parents relinquish custody

Health care industry spends $30b a year pushing its wares, from drugs to stem cell treatment

Health care industry spends $30b a year pushing its wares, from drugs to stem cell treatment

Cytek marks major milestone by shipping its 100th advanced flow cytometry system

Cytek marks major milestone by shipping its 100th advanced flow cytometry system

Research illuminates abilities of ADAR1 to ‘hyper-mutate’ tumor suppressor RNAs in leukemia

Research illuminates abilities of ADAR1 to ‘hyper-mutate’ tumor suppressor RNAs in leukemia

Research reviews role of protein tyrosine phosphatase in molecular biology

Research reviews role of protein tyrosine phosphatase in molecular biology

Scientists discover two therapies that slow progression of pediatric leukemia in mice

Scientists discover two therapies that slow progression of pediatric leukemia in mice

FDA approves new treatment for rare disease of the bone marrow and blood

FDA approves new treatment for rare disease of the bone marrow and blood

CHLA researcher reveals how leukemia burrows within the bone marrow

CHLA researcher reveals how leukemia burrows within the bone marrow

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.